Weight change after antiretroviral therapy and mortality.

Autor:	Yuh B; Yale University School of Medicine, New Haven., Tate J; Yale University School of Medicine, New Haven Veterans Affairs (VA) Connecticut Healthcare System, West Haven., Butt AA; VA Pittsburgh Healthcare System University of Pittsburgh School of Medicine, Pennsylvania., Crothers K; University of Washington School of Medicine, Seattle., Freiberg M; VA Pittsburgh Healthcare System University of Pittsburgh School of Medicine, Pennsylvania., Leaf D; UCLA School of Medicine Greater Los Angeles VA Healthcare System, California., Logeais M; University of Minnesota Medical School, Minneapolis., Rimland D; Atlanta VA Medical Center Emory University School of Medicine, Atlanta, Georgia., Rodriguez-Barradas MC; Michael E. Debakey VA Medical Center Baylor College of Medicine, Houston, Texas., Ruser C; Yale University School of Medicine, New Haven Veterans Affairs (VA) Connecticut Healthcare System, West Haven., Justice AC; Yale University School of Medicine, New Haven Veterans Affairs (VA) Connecticut Healthcare System, West Haven.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2015 Jun 15; Vol. 60 (12), pp. 1852-9. Date of Electronic Publication: 2015 Mar 11.
DOI:	10.1093/cid/civ192
Abstrakt:	Background: Weight gain after antiretroviral therapy (ART) initiation is common, but its implication for mortality is unknown. We evaluated weight change in the first year after ART initiation and its association with subsequent mortality. Methods: Human immunodeficiency virus-infected patients from the Veterans Aging Cohort Study (VACS) who initiated ART between 2000 and 2008, with weight recorded at baseline and 1 year later, were followed another 5 years for mortality. Baseline body mass index (BMI) was classified as underweight (<18.5 kg/m(2)), normal (18.5-24.9 kg/m(2)), overweight (25-29.9 kg/m(2)), and obese (≥30 kg/m(2)). We used multivariable Cox models to assess mortality risk with adjustment for disease severity using the VACS Index. Results: The sample consisted of 4184 men and 127 women with a mean age of 47.9 ± 10.0 years. After 1 year of ART, median weight change was 5.9 pounds (2.7 kg) (interquartile range, -2.9 to 17.0 pounds, -1.3 to 7.7 kg). Weight gain after ART initiation was associated with lower mortality among underweight and normal-weight patients. A minimum threshold of 10- to 19.9-pound (4.5 to 9.0 kg) weight gain was beneficial for normal-weight patients (hazard ratio, 0.56; 95% confidence interval, .41-.78), but there was no clear benefit to weight gain for overweight/obese patients. Baseline weight, CD4 cell count status, and hemoglobin level were strongly associated with weight gain. Risk for weight gain was higher among those with greater disease severity, regardless of weight at initiation. Conclusions: The survival benefits of weight gain after ART initiation are dependent on starting BMI. Weight gain after ART is associated with lower mortality for those who are not initially overweight. (© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu